Annual CFI
-$152.70 K
+$1.94 M+92.69%
31 December 2023
Summary:
SAB Biotherapeutics annual cash flow from investing activities is currently -$152.70 thousand, with the most recent change of +$1.94 million (+92.69%) on 31 December 2023. During the last 3 years, it has risen by +$12.57 million (+98.80%). SABS annual CFI is now at all-time high.SABS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$1.15 M
-$12.37 M-110.27%
30 September 2024
Summary:
SAB Biotherapeutics quarterly cash flow from investing activities is currently -$1.15 million, with the most recent change of -$12.37 million (-110.27%) on 30 September 2024. Over the past year, it has dropped by -$1.11 million (-2718.09%). SABS quarterly CFI is now -110.27% below its all-time high of $11.22 million, reached on 30 June 2024.SABS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$21.36 M
-$1.11 M-5.49%
30 September 2024
Summary:
SAB Biotherapeutics TTM cash flow from investing activities is currently -$21.36 million, with the most recent change of -$1.11 million (-5.49%) on 30 September 2024. Over the past year, it has dropped by -$21.16 million (-10438.18%). SABS TTM CFI is now -13879.65% below its all-time high of -$152.80 thousand, reached on 31 December 2023.SABS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +92.7% | -2718.1% | -10000.0% |
| 3 y3 years | +98.8% | +64.3% | -148.9% |
| 5 y5 years | - | - | - |
SABS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.8% | -110.3% | +96.3% | <-9999.0% | +32.2% |
| 5 y | 5 years | at high | +98.8% | -110.3% | +96.3% | <-9999.0% | +32.2% |
| alltime | all time | at high | +98.8% | -110.3% | +96.3% | <-9999.0% | +32.2% |
SAB Biotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.15 M(-110.3%) | -$21.36 M(+5.5%) |
| June 2024 | - | $11.22 M(-135.8%) | -$20.25 M(-35.7%) |
| Mar 2024 | - | -$31.36 M(>+9900.0%) | -$31.49 M(>+9900.0%) |
| Dec 2023 | -$152.70 K(-92.7%) | -$67.90 K(+66.0%) | -$152.80 K(-24.6%) |
| Sept 2023 | - | -$40.90 K(+80.2%) | -$202.70 K(-15.6%) |
| June 2023 | - | -$22.70 K(+6.6%) | -$240.30 K(-71.1%) |
| Mar 2023 | - | -$21.30 K(-81.9%) | -$830.40 K(-60.3%) |
| Dec 2022 | -$2.09 M | -$117.80 K(+50.1%) | -$2.09 M(-51.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$78.50 K(-87.2%) | -$4.33 M(-42.1%) |
| June 2022 | - | -$612.80 K(-52.2%) | -$7.48 M(-27.6%) |
| Mar 2022 | - | -$1.28 M(-45.8%) | -$10.33 M(-5.6%) |
| Dec 2021 | -$10.94 M(-14.0%) | -$2.36 M(-26.8%) | -$10.94 M(+27.5%) |
| Sept 2021 | - | -$3.23 M(-6.8%) | -$8.58 M(+60.3%) |
| June 2021 | - | -$3.46 M(+83.2%) | -$5.35 M(+183.2%) |
| Mar 2021 | - | -$1.89 M | -$1.89 M |
| Dec 2020 | -$12.72 M(+1990.1%) | - | - |
| Dec 2019 | -$608.70 K | - | - |
FAQ
- What is SAB Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual CFI year-on-year change?
- What is SAB Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly CFI year-on-year change?
- What is SAB Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM CFI year-on-year change?
What is SAB Biotherapeutics annual cash flow from investing activities?
The current annual CFI of SABS is -$152.70 K
What is the all time high annual CFI for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual cash flow from investing activities is -$152.70 K
What is SAB Biotherapeutics annual CFI year-on-year change?
Over the past year, SABS annual cash flow from investing activities has changed by +$1.94 M (+92.69%)
What is SAB Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SABS is -$1.15 M
What is the all time high quarterly CFI for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly cash flow from investing activities is $11.22 M
What is SAB Biotherapeutics quarterly CFI year-on-year change?
Over the past year, SABS quarterly cash flow from investing activities has changed by -$1.11 M (-2718.09%)
What is SAB Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of SABS is -$21.36 M
What is the all time high TTM CFI for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM cash flow from investing activities is -$152.80 K
What is SAB Biotherapeutics TTM CFI year-on-year change?
Over the past year, SABS TTM cash flow from investing activities has changed by -$21.16 M (-10438.18%)